INTRODUCTION & OBJECTIVES: The PADUA classification was introduced in 2009, but it has never been validated for the Tumor Enucleation (TE) technique. Aim of study was to assess the ability of PADUA score to predict the surgical results and complications of TE. MATERIAL & METHODS: We prospectively gathered data from 244 consecutive patients treated with open TE with warm ischemia. All clinical and surgical data, including PADUA score, were registered. The relationship between preoperative variables and surgical results/perioperative complications was assessed with univariate analysis and multivariate logistic regression model. RESULTS: Median PADUA score of renal tumors resulted 8 (IQR:7-9), and it was ≥ 10 in 52 (21.3%) patients. Mean warm ischemia time (WIT) was 16.8 min. Overall, 47 perioperative complications occurred in 45 patients (45/244 = 18.4%); of these, 39 (16%) were surgical and 8 (3.3%) medical. Surgical complications included blood loss treated with bedrest in 2 patients (0.8%), with transfusions in 25 (10.2%) and with a second invasive procedure in 5 (2.1%) patients. Urinary fistula occurred in 7 patients (2.9%); it was treated with bedrest and antibiotics in 4 (1.7%), while it needed ureteral stenting in the other 3 cases (1.2%). According to Clavien system, 8 surgical complications were grade 3 ( 3.3%), and no grade 4 and 5 surgical complications occurred in this series. At univariate analysis the PADUA score resulted significantly correlated with WIT (p<0.0001), estimated blood loss (p=0.003) and operative time (p=0.027). Significant predictors of overall surgical complications resulted the Charlson index (p<0.0001), the surgical indication (p=0.045), the tumor diameter (p=0.042) and the PADUA score (p=0.009). At the multivariate analysis, independent predictors of overall perioperative complications resulted PADUA score (RR=1.54; p=0.017) and the surgical indication (RR=2.59; p=0.019). Therefore, each point increase in PADUA score was associated with a 1.54-fold increase in the risk of complications after TE. The PADUA score was the only anatomical variable who independently predict the surgical complications (RR= 1.58; p=0.016), and Clavien grade III surgical complications (RR=2.99; p=0.008). CONCLUSIONS: The PADUA score was significantly associated with the surgical results of TE, and it resulted an independent predictor of overall complications, surgical complications, and Clavien grade III complications.

External validation of PADUA classification for the renal tumor enucleation technique / Vittori G.; Minervini A.; Salvi M.; Tuccio A.; Siena G.; Mantella A.; Sebastianelli A.; Saleh O.; Serni S.; Carini M.. - In: EUROPEAN UROLOGY. - ISSN 1828-6569. - STAMPA. - 11:(2012), pp. 136-136. [DOI: 10.1016/S1569-9056(12)60135-3]

External validation of PADUA classification for the renal tumor enucleation technique

VITTORI, GIANNI;MINERVINI, ANDREA;SALVI, MATTEO;TUCCIO, AGOSTINO;SIENA, GIAMPAOLO;MANTELLA, ANTONIA;SEBASTIANELLI, ARCANGELO;SALEH, OMAR;SERNI, SERGIO;CARINI, MARCO
2012

Abstract

INTRODUCTION & OBJECTIVES: The PADUA classification was introduced in 2009, but it has never been validated for the Tumor Enucleation (TE) technique. Aim of study was to assess the ability of PADUA score to predict the surgical results and complications of TE. MATERIAL & METHODS: We prospectively gathered data from 244 consecutive patients treated with open TE with warm ischemia. All clinical and surgical data, including PADUA score, were registered. The relationship between preoperative variables and surgical results/perioperative complications was assessed with univariate analysis and multivariate logistic regression model. RESULTS: Median PADUA score of renal tumors resulted 8 (IQR:7-9), and it was ≥ 10 in 52 (21.3%) patients. Mean warm ischemia time (WIT) was 16.8 min. Overall, 47 perioperative complications occurred in 45 patients (45/244 = 18.4%); of these, 39 (16%) were surgical and 8 (3.3%) medical. Surgical complications included blood loss treated with bedrest in 2 patients (0.8%), with transfusions in 25 (10.2%) and with a second invasive procedure in 5 (2.1%) patients. Urinary fistula occurred in 7 patients (2.9%); it was treated with bedrest and antibiotics in 4 (1.7%), while it needed ureteral stenting in the other 3 cases (1.2%). According to Clavien system, 8 surgical complications were grade 3 ( 3.3%), and no grade 4 and 5 surgical complications occurred in this series. At univariate analysis the PADUA score resulted significantly correlated with WIT (p<0.0001), estimated blood loss (p=0.003) and operative time (p=0.027). Significant predictors of overall surgical complications resulted the Charlson index (p<0.0001), the surgical indication (p=0.045), the tumor diameter (p=0.042) and the PADUA score (p=0.009). At the multivariate analysis, independent predictors of overall perioperative complications resulted PADUA score (RR=1.54; p=0.017) and the surgical indication (RR=2.59; p=0.019). Therefore, each point increase in PADUA score was associated with a 1.54-fold increase in the risk of complications after TE. The PADUA score was the only anatomical variable who independently predict the surgical complications (RR= 1.58; p=0.016), and Clavien grade III surgical complications (RR=2.99; p=0.008). CONCLUSIONS: The PADUA score was significantly associated with the surgical results of TE, and it resulted an independent predictor of overall complications, surgical complications, and Clavien grade III complications.
2012
Vittori G.; Minervini A.; Salvi M.; Tuccio A.; Siena G.; Mantella A.; Sebastianelli A.; Saleh O.; Serni S.; Carini M.
File in questo prodotto:
File Dimensione Formato  
Vittori_2012_European-Urology-Supplements.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 33.49 kB
Formato Adobe PDF
33.49 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1056795
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact